Global Neurosciences Institute Performs First SetPoint System Procedures in Southern New Jersey

FDA-approved neuroimmune modulation therapy is now available to eligible adults living with rheumatoid arthritis across Southern New Jersey, Delaware, and Eastern Pennsylvania. VALENCIA, Calif., September 28, 2026 — Global Neurosciences Institute (GNI), a leading group of medical specialties focused on delivering collaborative, patient-centered neurological care, and SetPoint® Medical, a commercial-stage medical technology company dedicated to […] The post Global Neurosciences Institute Performs First SetPoint System Procedures in Southern New Jersey appeared first on SetPoint Medical .